Rivaplast 9mg Transdermal Patch
Marketer
Zuventus Healthcare Ltd
Salt Composition
Rivastigmine (9mg)
Overview Rivaplast 9mg Transdermal Patch
The transdermal Rivaplast 9mg patch offers symptomatic relief for mild-to-moderate dementia associated with Alzheimer's disease, a progressively debilitating condition impacting cognitive function and memory. It's also indicated for dementia in Parkinson's disease. While not a cure, it can potentially alleviate symptoms, enhancing memory and alertness. Your physician will provide precise application instructions; adhere to these diligently for optimal results. Dosage adjustments may be necessary based on individual response. Apply only one patch at a time, replacing it daily with a new patch at a different location to prevent skin irritation. Symptom improvement may take up to four weeks; consistent use is vital. Commonly reported adverse effects include diarrhea, stomach pain, headache, dizziness, anxiety, fatigue, depression, delirium, restlessness, urinary tract infection, urinary leakage, and weight loss. These side effects may be more frequent initially or following dosage increases, typically subsiding as tolerance develops. If side effects persist or worsen, remove the patch and seek medical attention immediately. Prior to commencing Rivaplast 9mg patch therapy, disclose any history of cardiac issues, peptic ulcers, seizures, or respiratory conditions (such as asthma) to your doctor. Inform your doctor of all other medications you are taking, as interactions are possible. Pregnant or lactating women should seek medical advice before using this medication.
Uses of Rivaplast 9mg Transdermal Patch
Senile dementia of the Alzheimer type
Major Benefits of Rivaplast 9mg Transdermal Patch:
Administer this medication precisely as your physician directs. Always verify the dosage instructions on the packaging. Apply only to clean, dry skin. Peel away the patch's protective covering, avoiding contact with the adhesive surface. Secure the patch firmly to the skin with the adhesive side contacting the skin.
Common Side effects of Rivaplast 9mg Transdermal Patch:
- Abdominal pain
- Delirium (acute confusional state)
- Urinary tract infection
- Depression
- Fever
How to use Rivaplast 9mg Transdermal Patch:
Administer this medication according to your physician's prescribed dosage and schedule. Always verify the product information prior to application. Ensure the application area is clean and completely dry. Peel away the patch's protective covering. Avoid contact with the adhesive surface. Apply the patch firmly to the skin with the adhesive side facing down, ensuring even contact.
How Rivaplast 9mg Transdermal Patch works:
Cognitive decline characteristic of Alzheimer's results from impaired neuronal communication. The Rivaplast 9mg Transdermal Patch, a cholinesterase inhibitor, delivers its medication via dermal absorption into the systemic circulation. This increases acetylcholine, a neurotransmitter crucial for nerve signaling, thereby enhancing cognitive function and memory.
SAFETY ADVICE
AlcoholNone
No drug interaction detected.
PregnancyCONSULT YOUR DOCTOR
Using the Rivaplast 9mg transdermal patch during pregnancy poses a confirmed risk to the fetus. Its use should be avoided except in rare, life-threatening circumstances where the potential benefits outweigh the known hazards, as determined by a physician. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Rivaplast 9mg Transdermal Patches while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingNone
No known drug interactions.
KidneySAFE IF PRESCRIBED
The 9mg Rivaplast transdermal patch can be used safely by patients with kidney disease; no dosage alteration is necessary. Nevertheless, disclose any pre-existing kidney conditions to your physician, as careful observation is recommended during treatment.
LiverSAFE IF PRESCRIBED
For patients with liver disease, the 9mg Rivaplast transdermal patch is considered safe, and no dosage modification is necessary. Nevertheless, disclosure of any pre-existing liver condition to your physician is crucial, as careful observation during treatment is recommended.
What if you forget to take Rivaplast 9mg Transdermal Patch :
Omit any missed Rivaplast 9mg Transdermal Patch application and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Rivaplast 9mg Transdermal Patch
| Label | Value |
|---|---|
| Chemical Type | Carbamate-based Compound |
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
3,018 People bought this recently